L. A. Shmidt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
L. A. Shmidt has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Anatoly Nikolaevich Kondratyev
Polenov Neurosurgical Institute, Branch of the Almazov National Medical Research Centre
3 shared publications - Lyubov M. Tsentsiper
Almazov National Medical Research Center
3 shared publications - M. I. Aybazova
Polenov Neurosurgical Institute – Branch of the Almazov National Medical Research Center
3 shared publications - Natalia Dryagina
Polenov Neurosurgical Institute, Branch of the Almazov National Medical Research Centre
3 shared publications - N. V. Goncharuk
V. A. Almazov National Medical Research Center, Ministry of Health of Russia
2 shared publications - E. S. Borisova
V. A. Almazov National Medical Research Center, Ministry of Health of Russia
1 shared publication
Latest Publications
- Open Access
- 6 June 2026
- Published by Arterialnaya Gipertenziya in Russian Journal for Personalized Medicine
- Vol. 6 (2) , 119-126
Determination of diagnostic criteria for nosocomial meningitis based on database analysis Polenov Russian Scientific Research Institute of Neurosurgery – branch of the Almazov National Medical Research Centre
The issue of objectifying the diagnosis of nosocomial meningitis (NM) remains relevant due to the lack of unified criteria for verifying this complication. The aim of this study was to optimize the diagnostic parameters for NM based on an analysis of clinical and laboratory data from patients of the Polenov Neurosurgical Institute (a branch of the V. A. Almazov NMRC). An open-label, single-center prospective study was conducted in the Department of Anesthesiology and Intensive Care from 2020 to 2025, enrolling 120 patients aged over 18 years who had undergone intracranial procedures. The control cohort (n=60) consisted of individuals without signs of NM, while the main cohort (n=60) comprised patients with a confirmed diagnosis of NM. A comparative assessment ofthe diagnostic significance ofinternational and domestic criteria for NM revealed the following: the sensitivity and specificity of the CDC criteria were 81.67 % and 83.33 %, respectively; for the probable NM criteria (Burdenko Center) ‒ 81.67 % and 88.33 %; and for the confirmed NM criteria (Burdenko Center) ‒ 51.67 % and 100 %. Optimization of threshold valuesfor clinical and laboratory parameters based on empirical data from the Polenov Institute improved diagnostic accuracy: the developed criteria provide a sensitivity of 90.0 % (54 out of 60 patients in the main group) and a specificity of 91.67 % (5 false positive results in the control group). The proposed diagnostic algorithm may serve as a basis for improving the early diagnosis of nosocomial meningitis.
- 6 June 2026
- Published by Arterialnaya Gipertenziya in Russian Journal for Personalized Medicine
- Vol. 6 (2) , 119-126
Open AccessDetermination of diagnostic criteria for nosocomial meningitis based on database analysis Polenov Russian Scientific Research Institute of Neurosurgery – branch of the Almazov National Medical Research Centre
The issue of objectifying the diagnosis of nosocomial meningitis (NM) remains relevant due to the lack of unified criteria for verifying this complication. The aim of this study was to optimize the diagnostic parameters for NM based on an analysis of clinical and laboratory data from patients of the Polenov Neurosurgical Institute (a branch of the V. A. Almazov NMRC). An open-label, single-center prospective study was conducted in the Department of Anesthesiology and Intensive Care from 2020 to 2025, enrolling 120 patients aged over 18 years who had undergone intracranial procedures. The control cohort (n=60) consisted of individuals without signs of NM, while the main cohort (n=60) comprised patients with a confirmed diagnosis of NM. A comparative assessment ofthe diagnostic significance ofinternational and domestic criteria for NM revealed the following: the sensitivity and specificity of the CDC criteria were 81.67 % and 83.33 %, respectively; for the probable NM criteria (Burdenko Center) ‒ 81.67 % and 88.33 %; and for the confirmed NM criteria (Burdenko Center) ‒ 51.67 % and 100 %. Optimization of threshold valuesfor clinical and laboratory parameters based on empirical data from the Polenov Institute improved diagnostic accuracy: the developed criteria provide a sensitivity of 90.0 % (54 out of 60 patients in the main group) and a specificity of 91.67 % (5 false positive results in the control group). The proposed diagnostic algorithm may serve as a basis for improving the early diagnosis of nosocomial meningitis.
- Open Access
- 4 November 2025
- Published by FSBI SRIGR RAMS in General Reanimatology
- Vol. 21 (5) , 26-34
The Potential for Improving the Diagnostics of Nosocomial Meningitis and Ventriculitis
The aim of the study was to identify the most specific and sensitive criteria for diagnosing nosocomial meningitis and ventriculitis. Materials and methods. A retrospective case-control cohort study conducted at the department of anesthesiology and intensive care of the A. L. Polenov Russian Research Neurosurgical Institute (RRNI), a branch of the V. A. Almazov National Medical Research Center (NMRC) of the Ministry of Health of Russia included 120 patients who underwent intracranial neurosurgery: the main group ( N =60) — patients with nosocomial meningitis (NM), and the comparison group ( N =60) — patients without NM. Inclusion criteria: age over 18 years. Exclusion criteria: severe immunosuppressive condition (HIV infection), signs of central nervous system (CNS) infection (meningitis, ventriculitis, brain abscess) on admission, extracranial surgical interventions, pre-operative cerebrospinal fluid leakage, CNS trauma, and extracranial causes of CNS infection. The US Centers for Disease Control and Prevention (CDC) and the Burdenko National Medical Research Center for Neurosurgery criteria for NM diagnosis were used in the study. Results. External validation of the NM diagnostic criteria in the analyzed patient cohort resulted in 81.67% sensitivity and 83.33% specificity of the CDC criteria. Sensitivity and specificity of the Burdenko National Medical Research Center for Neurosurgery criteria were 81.67% and 88.33%, respectively, for probable NM, and 51.67% and 100%, for confirmed NM. The CDC criteria demonstrated the highest sensitivity for protein concentration in cerebrospinal fluid (CSF) > 0.33 g/L (83.6%), with simultaneous extremely low specificity of 21%, and the highest specificity for the CSF positive culture (100%). As for the Burdenko National Research Medical Center for Neurosurgery criteria, in probable NM the highest sensitivity was established for CSF cell count > 65 cells/µL (64.4%), and the highest specificity — for CSF glucose < 2.6 mmol/l (93.9%) and CSF/serum glucose ratio (CSF/SGLU) < 0.45 (96.8%). In confirmed NM, CSF cell count > 65 cells/µL was also the most sensitive parameter (95.2%), although with 51% specificity. The highest specificity was found for the CSF lactate > 4.2 mmol/L (92.3%). The optimal threshold values were calculated for four parameters: body temperature > 37.7°C, CSF cell count > 245 cells/µL, CSF glucose < 2.0 mmol/L, and CSF lactate > 3.7 mmol/L. Using a combination of threshold values for all four parameters, we achieved a sensitivity of 90.00% and a specificity of 91.67%. CSF cell count (AUC=0.90; 95% CI 0.84–0.95), increased CSF lactate (AUC=0.85; 95% CI 0.75–0.93), total CSF protein (AUC=0.83; 95% CI 0.75–0.90) and body temperature (AUC=0.82; 95% CI 0.74–0.89) had the greatest diagnostic value. Positive CSF culture and the occipital muscle rigidity correlated with the diagnosis of NM ( rbp =0.522 and rbp =0.415, respectively, P =0.0001), but did not show good predictive diagnostic capacity. Conclusion. Fever, increase in CSF cell count and CSF lactate were identified as the most clinically significant signs of NM. A positive CF culture traditionally used as the gold standard for diagnosis of NM showed low sensitivity of 69.2%. When taken together, the identified in the study threshold values of body temperature, CSF cell count, CSF glucose and lactate have a higher sensitivity and specificity than those used earlier.
- 4 November 2025
- Published by FSBI SRIGR RAMS in General Reanimatology
- Vol. 21 (5) , 26-34
Open AccessThe Potential for Improving the Diagnostics of Nosocomial Meningitis and Ventriculitis
The aim of the study was to identify the most specific and sensitive criteria for diagnosing nosocomial meningitis and ventriculitis. Materials and methods. A retrospective case-control cohort study conducted at the department of anesthesiology and intensive care of the A. L. Polenov Russian Research Neurosurgical Institute (RRNI), a branch of the V. A. Almazov National Medical Research Center (NMRC) of the Ministry of Health of Russia included 120 patients who underwent intracranial neurosurgery: the main group ( N =60) — patients with nosocomial meningitis (NM), and the comparison group ( N =60) — patients without NM. Inclusion criteria: age over 18 years. Exclusion criteria: severe immunosuppressive condition (HIV infection), signs of central nervous system (CNS) infection (meningitis, ventriculitis, brain abscess) on admission, extracranial surgical interventions, pre-operative cerebrospinal fluid leakage, CNS trauma, and extracranial causes of CNS infection. The US Centers for Disease Control and Prevention (CDC) and the Burdenko National Medical Research Center for Neurosurgery criteria for NM diagnosis were used in the study. Results. External validation of the NM diagnostic criteria in the analyzed patient cohort resulted in 81.67% sensitivity and 83.33% specificity of the CDC criteria. Sensitivity and specificity of the Burdenko National Medical Research Center for Neurosurgery criteria were 81.67% and 88.33%, respectively, for probable NM, and 51.67% and 100%, for confirmed NM. The CDC criteria demonstrated the highest sensitivity for protein concentration in cerebrospinal fluid (CSF) > 0.33 g/L (83.6%), with simultaneous extremely low specificity of 21%, and the highest specificity for the CSF positive culture (100%). As for the Burdenko National Research Medical Center for Neurosurgery criteria, in probable NM the highest sensitivity was established for CSF cell count > 65 cells/µL (64.4%), and the highest specificity — for CSF glucose < 2.6 mmol/l (93.9%) and CSF/serum glucose ratio (CSF/SGLU) < 0.45 (96.8%). In confirmed NM, CSF cell count > 65 cells/µL was also the most sensitive parameter (95.2%), although with 51% specificity. The highest specificity was found for the CSF lactate > 4.2 mmol/L (92.3%). The optimal threshold values were calculated for four parameters: body temperature > 37.7°C, CSF cell count > 245 cells/µL, CSF glucose < 2.0 mmol/L, and CSF lactate > 3.7 mmol/L. Using a combination of threshold values for all four parameters, we achieved a sensitivity of 90.00% and a specificity of 91.67%. CSF cell count (AUC=0.90; 95% CI 0.84–0.95), increased CSF lactate (AUC=0.85; 95% CI 0.75–0.93), total CSF protein (AUC=0.83; 95% CI 0.75–0.90) and body temperature (AUC=0.82; 95% CI 0.74–0.89) had the greatest diagnostic value. Positive CSF culture and the occipital muscle rigidity correlated with the diagnosis of NM ( rbp =0.522 and rbp =0.415, respectively, P =0.0001), but did not show good predictive diagnostic capacity. Conclusion. Fever, increase in CSF cell count and CSF lactate were identified as the most clinically significant signs of NM. A positive CF culture traditionally used as the gold standard for diagnosis of NM showed low sensitivity of 69.2%. When taken together, the identified in the study threshold values of body temperature, CSF cell count, CSF glucose and lactate have a higher sensitivity and specificity than those used earlier.
- Open Access
- 27 June 2025
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Messenger of ANESTHESIOLOGY AND RESUSCITATION
- Vol. 22 (3) , 108-118
Nosocomial meningitis and ventriculitis: clinic, diagnosis, prevention (literature review)
The objective was to summarize data from the literature on methods of diagnosis and prevention of nosocomial meningitis.Nosocomial meningitis (NM) and ventriculitis are severe, often life-threatening complications in neurosurgery. Currently, postoperative meningitis, shunt infections, and drainage-associated ventriculitis are distinguished. For each of the above groups of diseases, there are specific diagnostic approaches, etiotropic agents, and treatments that differ significantly from community-acquired infections of the central nervous system. Pathogens are represented by a wide range of opportunistic and pathogenic microorganisms, which differ significantly from community-acquired ones. The diagnosis of NM is based mainly on clinical assessment and laboratory examination of cerebrospinal fluid. In most recommendations, there are no precise laboratory criteria for the diagnosis of NM, which is explained by the variability of shifts depending on the microorganism that caused the infection and on the individual characteristics of the patient, as well as the variety of clinical situations. NM prevention is based on minimizing risk factors, includes measures against endogenous and exogenous infection, and can be divided into three stages: preoperative, intraoperative and postoperative. The development of criteria for NM and ventriculitis, the identification of risk factors remains an important problem that has not been definitively solved to date.
- 27 June 2025
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Messenger of ANESTHESIOLOGY AND RESUSCITATION
- Vol. 22 (3) , 108-118
Open AccessNosocomial meningitis and ventriculitis: clinic, diagnosis, prevention (literature review)
The objective was to summarize data from the literature on methods of diagnosis and prevention of nosocomial meningitis.Nosocomial meningitis (NM) and ventriculitis are severe, often life-threatening complications in neurosurgery. Currently, postoperative meningitis, shunt infections, and drainage-associated ventriculitis are distinguished. For each of the above groups of diseases, there are specific diagnostic approaches, etiotropic agents, and treatments that differ significantly from community-acquired infections of the central nervous system. Pathogens are represented by a wide range of opportunistic and pathogenic microorganisms, which differ significantly from community-acquired ones. The diagnosis of NM is based mainly on clinical assessment and laboratory examination of cerebrospinal fluid. In most recommendations, there are no precise laboratory criteria for the diagnosis of NM, which is explained by the variability of shifts depending on the microorganism that caused the infection and on the individual characteristics of the patient, as well as the variety of clinical situations. NM prevention is based on minimizing risk factors, includes measures against endogenous and exogenous infection, and can be divided into three stages: preoperative, intraoperative and postoperative. The development of criteria for NM and ventriculitis, the identification of risk factors remains an important problem that has not been definitively solved to date.